20 related articles for article (PubMed ID: 38613458)
1. α4 nicotinic receptors on GABAergic neurons mediate a cholinergic analgesic circuit in the substantia nigra pars reticulata.
Han Y; Zhang JQ; Ji YW; Luan YW; Li SY; Geng HZ; Ji Y; Yin C; Liu S; Zhou CY; Xiao C
Acta Pharmacol Sin; 2024 Jun; 45(6):1160-1174. PubMed ID: 38438581
[TBL] [Abstract][Full Text] [Related]
2. Reduced levels of Cacna1c attenuate mesolimbic dopamine system function.
Terrillion CE; Dao DT; Cachope R; Lobo MK; Puche AC; Cheer JF; Gould TD
Genes Brain Behav; 2017 Jun; 16(5):495-505. PubMed ID: 28186690
[TBL] [Abstract][Full Text] [Related]
3. Increased presynaptic regulation of dopamine neurotransmission in the nucleus accumbens core following chronic ethanol self-administration in female macaques.
Siciliano CA; Calipari ES; Yorgason JT; Lovinger DM; Mateo Y; Jimenez VA; Helms CM; Grant KA; Jones SR
Psychopharmacology (Berl); 2016 Apr; 233(8):1435-43. PubMed ID: 26892380
[TBL] [Abstract][Full Text] [Related]
4. Temporal Rewiring of Striatal Circuits Initiated by Nicotine.
Adermark L; Morud J; Lotfi A; Danielsson K; Ulenius L; Söderpalm B; Ericson M
Neuropsychopharmacology; 2016 Dec; 41(13):3051-3059. PubMed ID: 27388328
[TBL] [Abstract][Full Text] [Related]
5. Nicotine addiction: More than just dopamine.
Kim K; Picciotto MR
Curr Opin Neurobiol; 2023 Dec; 83():102797. PubMed ID: 37832393
[TBL] [Abstract][Full Text] [Related]
6. Fluorocitrate inhibition of astrocytes reduces nicotine self-administration and alters extracellular levels of glutamate and dopamine within the nucleus accumbens in male wistar rats.
Tan X; Neslund EM; Fentis K; Ding ZM
Neuropharmacology; 2024 May; 255():110001. PubMed ID: 38750804
[TBL] [Abstract][Full Text] [Related]
7. Striatal dopamine transmission is reduced after chronic nicotine with a decrease in α6-nicotinic receptor control in nucleus accumbens.
Exley R; Clements MA; Hartung H; McIntosh JM; Franklin M; Bermudez I; Cragg SJ
Eur J Neurosci; 2013 Oct; 38(7):3036-43. PubMed ID: 23841846
[TBL] [Abstract][Full Text] [Related]
8. Alpha6-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens.
Exley R; Clements MA; Hartung H; McIntosh JM; Cragg SJ
Neuropsychopharmacology; 2008 Aug; 33(9):2158-66. PubMed ID: 18033235
[TBL] [Abstract][Full Text] [Related]
9. Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2* receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement.
Gotti C; Guiducci S; Tedesco V; Corbioli S; Zanetti L; Moretti M; Zanardi A; Rimondini R; Mugnaini M; Clementi F; Chiamulera C; Zoli M
J Neurosci; 2010 Apr; 30(15):5311-25. PubMed ID: 20392953
[TBL] [Abstract][Full Text] [Related]
10. Acute ethanol inhibits dopamine release in the nucleus accumbens via α6 nicotinic acetylcholine receptors.
Schilaty ND; Hedges DM; Jang EY; Folsom RJ; Yorgason JT; McIntosh JM; Steffensen SC
J Pharmacol Exp Ther; 2014 Jun; 349(3):559-67. PubMed ID: 24643637
[TBL] [Abstract][Full Text] [Related]
11. Role of α6-Nicotinic Receptors in Alcohol-Induced GABAergic Synaptic Transmission and Plasticity to Cholinergic Interneurons in the Nucleus Accumbens.
Wadsworth HA; Anderson EQ; Williams BM; Ronström JW; Moen JK; Lee AM; McIntosh JM; Wu J; Yorgason JT; Steffensen SC
Mol Neurobiol; 2023 Jun; 60(6):3113-3129. PubMed ID: 36802012
[TBL] [Abstract][Full Text] [Related]
12. Catharanthine Modulates Mesolimbic Dopamine Transmission and Nicotine Psychomotor Effects via Inhibition of α6-Nicotinic Receptors and Dopamine Transporters.
Williams BM; Steed ND; Woolley JT; Moedl AA; Nelson CA; Jones GC; Burris MD; Arias HR; Kim OH; Jang EY; Hone AJ; McIntosh JM; Yorgason JT; Steffensen SC
ACS Chem Neurosci; 2024 May; 15(9):1738-1754. PubMed ID: 38613458
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
